Symptom burden and outcomes in patients with platinum resistant/refractory (PRR) and potentially platinum sensitive ROC receiving ≥3 lines of chemotherapy (PPS ≥3) – The Gynecologic Cancer Intergroup (GCIG) Symptom Benefit Study (SBS)

Autor:	Florian Heitz, V Hilpert, T Fehm, M Friedlander, I Rohr, U Canzler
Rok vydání:	2017
Předmět:	Gerontology Oncology medicine.medical_specialty Chemotherapy business.industry medicine.medical_treatment Symptom burden Refractory Internal medicine Gynecologic cancer medicine Platinum sensitive In patient business Platinum resistant
Zdroj:	Geburtshilfe und Frauenheilkunde.
ISSN:	1438-8804
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::f309028afe95c66c2106db30a4d68894 https://doi.org/10.1055/s-0037-1602307 Zobrazit plný text záznamu